» Articles » PMID: 32487265

Decreased Nuclear Pten in Neural Stem Cells Contributes to Deficits in Neuronal Maturation

Overview
Journal Mol Autism
Publisher Biomed Central
Date 2020 Jun 4
PMID 32487265
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: PTEN, a syndromic autism spectrum disorder (ASD) risk gene, is mutated in approximately 10% of macrocephalic ASD cases. Despite the described genetic association between PTEN and ASD and ensuing studies, we continue to have a limited understanding of how PTEN disruption drives ASD pathogenesis and maintenance.

Methods: We derived neural stem cells (NSCs) from the dentate gyrus (DG) of Pten mice, a model that recapitulates PTEN-ASD phenotypes. We subsequently characterized the expression of stemness factors, proliferation, and differentiation of neurons and glia in Pten NSCs using immunofluorescent and immunoblotting approaches. We also measured Creb phosphorylation by Western blot analysis and expression of Creb-regulated genes with qRT-PCR.

Results: The m3m4 mutation decreases Pten localization to the nucleus and its global expression over time. Pten NSCs exhibit persistent stemness characteristics associated with increased proliferation and a resistance to neuronal maturation during differentiation. Given the increased proliferation of Pten NSCs, a significant increase in the population of immature neurons relative to mature neurons occurs, an approximately tenfold decrease in the ratio between the homozygous mutant and wildtype. There is an opposite pattern of differentiation in some Pten glia, specifically an increase in astrocytes. These aberrant differentiation patterns associate with changes in Creb activation in Pten NSCs. We specifically observed loss of Creb phosphorylation at S133 in Pten NSCs and a subsequent decrease in expression of Creb-regulated genes important to neuronal function (i.e., Bdnf). Interestingly, Bdnf treatment is able to partially rescue the stunted neuronal maturation phenotype in Pten NSCs.

Conclusions: Constitutional disruption of Pten nuclear localization with subsequent global decrease in Pten expression generates abnormal patterns of differentiation, a stunting of neuronal maturation. The propensity of Pten disruption to restrain neurons to a more progenitor-like state may be an important feature contributing to PTEN-ASD pathogenesis.

Citing Articles

Therapeutic role of PTEN in tissue regeneration for management of neurological disorders: stem cell behaviors to an in-depth review.

Li Y, Ma R, Hao X Cell Death Dis. 2024; 15(4):268.

PMID: 38627382 PMC: 11021430. DOI: 10.1038/s41419-024-06657-y.


Topologically associating domains define the impact of de novo promoter variants on autism spectrum disorder risk.

Nakamura T, Ueda J, Mizuno S, Honda K, Kazuno A, Yamamoto H Cell Genom. 2024; 4(2):100488.

PMID: 38280381 PMC: 10879036. DOI: 10.1016/j.xgen.2024.100488.


Germline PTEN genotype-dependent phenotypic divergence during the early neural developmental process of forebrain organoids.

Kang S, Sarn N, Venegas J, Tan Z, Hitomi M, Eng C Mol Psychiatry. 2023; 29(6):1767-1781.

PMID: 38030818 DOI: 10.1038/s41380-023-02325-3.


Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers.

Langdon C Biomolecules. 2023; 13(2).

PMID: 36830628 PMC: 9953540. DOI: 10.3390/biom13020259.


Germline nuclear-predominant Pten murine model exhibits impaired social and perseverative behavior, microglial activation, and increased oxytocinergic activity.

Sarn N, Thacker S, Lee H, Eng C Mol Autism. 2021; 12(1):41.

PMID: 34088332 PMC: 8176582. DOI: 10.1186/s13229-021-00448-4.


References
1.
Zhou J, Blundell J, Ogawa S, Kwon C, Zhang W, Sinton C . Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci. 2009; 29(6):1773-83. PMC: 3904448. DOI: 10.1523/JNEUROSCI.5685-08.2009. View

2.
McBride K, Varga E, Pastore M, Prior T, Manickam K, Atkin J . Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res. 2010; 3(3):137-41. DOI: 10.1002/aur.132. View

3.
Zheng H, Ying H, Yan H, Kimmelman A, Hiller D, Chen A . Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harb Symp Quant Biol. 2009; 73:427-37. DOI: 10.1101/sqb.2008.73.047. View

4.
Tan M, Mester J, Ngeow J, Rybicki L, Orloff M, Eng C . Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012; 18(2):400-7. PMC: 3261579. DOI: 10.1158/1078-0432.CCR-11-2283. View

5.
Lancaster M, Renner M, Martin C, Wenzel D, Bicknell L, Hurles M . Cerebral organoids model human brain development and microcephaly. Nature. 2013; 501(7467):373-9. PMC: 3817409. DOI: 10.1038/nature12517. View